Michelle Obama’s new photoshoot showing a slimmer look. (Photo: IG/michelleobama)
Netizens are now speaking about Ozempic, the diabetes medication widely discussed for its off-label weight-loss effects is back in the spotlight after social media users linked it to former US First Lady Michelle Obama’s recent appearance.
Ozempic, which contains the active ingredient semaglutide, is approved to treat type-2 diabetes, regulate blood sugar levels, reduce cardiovascular risks and prevent kidney-related complications. Although weight loss can occur as a secondary effect, the drug is not FDA-approved for cosmetic or standalone weight-loss use.
A behind-the-scenes video from Michelle Obama’s new photoshoot with acclaimed photographer Annie Leibovitz part of her Women project campaign has ignited a wave of online chatter. In the footage, Obama appears noticeably slimmer, dressed casually in a grey T-shirt, jeans and suede boots.
However, instead of focusing on the campaign’s message or her long history of promoting healthy living, many social media users shifted attention to her physique. Comments across Instagram and X quickly speculated whether she is using Ozempic.
“Ozempic, just like everyone on The View who suddenly decided to ‘get healthy’,” one user wrote.
Another said, “It’s called Ozempic,” while a third asked, “IS MICHELLE ON OZEMPIC?”
A fourth commented: “Personal trainer and strict diet? Nah Ozempic is way easier.”
Despite the speculation, there is no evidence linking Michelle Obama to Ozempic or any similar medication, nor has she made any statement addressing the claims.
Ozempic is a once-weekly injectable medication used to treat adults with type-2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which help:
Manage blood sugar levels alongside diet and exercise
Lower heart attack and stroke risk in diabetic patients with heart disease
Slow kidney function decline in those with chronic kidney disease
Reduce certain cardiovascular risks
Doctors may prescribe it off-label for weight loss, but the FDA has not approved Ozempic for that purpose. The drug also carries a boxed warning the FDA’s most serious caution outlining potential risks that patients must consider before use.
Michelle Obama’s case highlights a broader trend: any rapid or noticeable physical transformation among public figures often leads to assumptions about GLP-1 drugs. As Ozempic, Wegovy and similar medications dominate health and pop culture conversations, celebrity appearances frequently become targets for unverified claims.
In Obama’s case, the buzz underscores how quickly online discourse shifts from a public figure’s work to their body even without credible evidence or confirmation.
ALSO READ: Why You Should Eat Dinner Earlier In Winter: Science Explains The Ideal Timing For Better Health
Sofia Babu Chacko is a journalist with over five years of experience covering Indian politics, crime, human rights, gender issues, and stories about marginalized communities. She believes that every voice matters, and journalism has a vital role to play in amplifying those voices. Sofia is committed to creating impact and shedding light on stories that truly matter. Beyond her work in the newsroom, she is also a music enthusiast who enjoys singing.
Iran warns the US its forces have “fingers on the trigger” and will respond immediately…
Beating Retreat 2026: Delhi Police announces traffic restrictions & route diversions near Vijay Chowk, plan…
IND vs NZ: Shivam Dube’s 15-Ball Fifty In Vain As New Zealand Beat India By 50 Runs in 4th T20I
The southpaw Dube flickered brightly with a blazing half-century but it was insufficient to prevent…
